IncontiLase
IncontiLase Treatment
A Breakthrough in Treating Stress Urinary Incontinence at Centrepointe Medical
At Centrepointe Medical in Ottawa, we specialize in providing innovative and effective solutions for sexual rejuvenation in women, with a keen focus on treating stress urinary incontinence (SUI) through IncontiLase® treatment.
Understanding Stress Urinary Incontinence
Stress Urinary Incontinence (SUI) is a common condition where women experience involuntary leakage of urine during physical activities, coughing, sneezing, or laughing. It’s often linked to weakened pelvic floor muscles, often due to childbirth, aging, or hormonal changes.
Introducing IncontiLase®
IncontiLase® represents a groundbreaking approach in SUI treatment. With its patent-pending technology, this non-invasive Er: YAG laser therapy targets mild and moderate SUI through non-ablative photothermal stimulation of collagen neogenesis. This process leads to the shrinking and tightening of vaginal mucosa tissue and the collagen-rich endopelvic fascia, offering greater support to the bladder.
The Science Behind IncontiLase®
Utilizing Fotona’s 2940 nm Er: YAG laser and proprietary “Smooth-mode” technology, IncontiLase® thermally affects vaginal tissue. It stimulates collagen remodelling and the synthesis of new collagen fibres in the vestibule and urethral orifice, as well as the anterior vaginal wall. The result is a tissue rejuvenation, leading to greater bladder support and restoration of normal continence function.
What is IncontiLase®?
IncontiLase® is a innovative and unique, patent-pending, non-invasive Er:YAG laser therapy for incontinence. It is based on non-ablative photothermal tension and shrinkage of the urethral and anterior bladder wall region. The indications for IncontiLase® therapy are mild and moderate stress and mixed urinary incontinence (SUI). Preliminary clinical studies show that it is an efficient, easyto-perform and safe procedure.
How does IncontiLase® work?
The IncontiLase® treatment is based on precisely controlled laser-induced thermal effects in the mucosa tissue in the region of the vestibule and urethral orifice, as well as in the area along the anterior vaginal wall.
The laser used in IntimaLase clinical trials is a 2940 nm Er:YAG, with builtin proprietary technology solutions that enable delivery of specially composed laser energy packages to the vaginal mucosa tissue and to collagen-rich endopelvic fascia.
Studies have shown that the resulting collagen neogenesis and remodeling leads to the shrinking and tightening of irradiated tissues, and the return of normal continence function.
Unique advantages of IncontiLase® for your patients
For a large majority of patients included in the study, a single session was sufficient to alleviate mild or even moderate stress urinary incontinence. If needed, the treatment was repeated after one month. No special pre-op preparations or postop precautions were necessary. Patients could immediately return to their normal everyday activities. Additional advantages of IncontiLase® are that the procedure is incisionless and virtually painless, with no ablation, cutting, bleeding, or sutures. Recovery is extremely quick without need for the use of analgesics or antibiotics.
Promising clinical results
The latest IncontiLase® scientific results, presented by LA&HA specialists Dr. Riviera and Dr. Fistonić, show excellent improvement for mild and moderate stress urinary incontinence. Assessments of efficacy were based on subjective patients’ evaluations through standardized questionnaires as well as objective Q-tip and PFM measurements. 90% of patients with mild SUI and 76% of patients with moderate SUI needed just a single IncontiLase® treatment. In total, 95% of all patients were incontinence free 12 months after the treatment, while 5% still had mild stress incontinence.
Take the First Step
Embrace a life free from the constraints of SUI. Contact Centrepointe Medical today to learn about IncontiLase® treatment and schedule your consultation.